Trevi Therapeutics, Inc. Common Stock (TRVI) News
Latest headlines that mention TRVI, newest first · each headline opens the original publisher
- Last price
- $13.94
- Day change
- +8.82%
- Next earnings
- 2026-11-09 AMC
TRVI headlines
latest coverageNot much coverage yet. TRVI has appeared in only a few headlines lately; new stories show up here as publishers cover it.
This clinical-stage biotech targets chronic pruritus and cough with its lead therapy for neurologically mediated diseases.
TRVI news alerts
Get an alert by email or push when a new headline mentions TRVI.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.